Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $749.25 | 15 | 51.2% |
| Travel and Lodging | $445.35 | 2 | 30.5% |
| Food and Beverage | $267.76 | 5 | 18.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Coloplast Corp | $1,191 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $85.26 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $85.00 | 1 | $0 (2019) |
| PFIZER INC. | $53.66 | 1 | $0 (2018) |
| Rochester Medical Corporation | $24.34 | 2 | $0 (2022) |
| Retrophin, Inc. | $15.61 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $28.16 | 3 | Rochester Medical Corporation ($24.34) |
| 2021 | $3.82 | 1 | Travere Therapeutics, Inc. ($3.82) |
| 2019 | $700.80 | 8 | Coloplast Corp ($610.85) |
| 2018 | $592.56 | 4 | Coloplast Corp ($450.00) |
| 2017 | $137.02 | 6 | Coloplast Corp ($130.00) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/08/2022 | Rochester Medical Corporation | — | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Medical Systems | ||||||
| 04/15/2022 | Rochester Medical Corporation | — | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Medical Systems | ||||||
| 02/17/2022 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 01/14/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 10/11/2019 | Coloplast Corp | TITAN (Device) | Education | Cash or cash equivalent | $61.00 | General |
| Category: PENILE RECONSTRUCTION | ||||||
| 08/02/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.31 | General |
| Category: Kidney Stones | ||||||
| 07/31/2019 | Coloplast Corp | TITAN (Device) | Travel and Lodging | Cash or cash equivalent | $77.79 | General |
| Category: PENILE RECONSTRUCTION | ||||||
| 07/19/2019 | Coloplast Corp | TITAN (Device) | Food and Beverage | Cash or cash equivalent | $104.50 | General |
| Category: PENILE RECONSTRUCTION | ||||||
| 07/01/2019 | Coloplast Corp | TITAN (Device) | Travel and Lodging | Cash or cash equivalent | $367.56 | General |
| Category: PENILE RECONSTRUCTION | ||||||
| 04/30/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.00 | General |
| 04/12/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $2.33 | General |
| Category: Kidney Stones | ||||||
| 04/12/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.31 | General |
| Category: Kidney Stones | ||||||
| 10/18/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $3.64 | General |
| Category: Kidney Stones | ||||||
| 06/04/2018 | Coloplast Corp | TITAN (Device) | Education | Cash or cash equivalent | $450.00 | General |
| Category: PENILE RECONSTRUCTION | ||||||
| 05/21/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $85.26 | General |
| Category: ONCOLOGY | ||||||
| 05/20/2018 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $53.66 | General |
| 11/01/2017 | Coloplast Corp | TITAN (Device) | Education | Cash or cash equivalent | $130.00 | General |
| Category: PENILE RECONSTRUCTION | ||||||
| 07/26/2017 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $2.52 | General |
| Category: Kidney Stones | ||||||
| 07/26/2017 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.71 | General |
| Category: Kidney Stones | ||||||
| 07/26/2017 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $0.54 | General |
| Category: Kidney Stones | ||||||
| 07/17/2017 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.71 | General |
| Category: Kidney Stones | ||||||
| 07/17/2017 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $0.54 | General |
| Category: Kidney Stones | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 763 | 999 | $325,896 | $75,011 |
| 2022 | 23 | 1,325 | 1,746 | $591,114 | $145,412 |
| 2021 | 22 | 1,297 | 1,747 | $512,726 | $138,398 |
| 2020 | 19 | 1,170 | 1,602 | $454,336 | $120,623 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 87 | 105 | $74,040 | $17,661 | 23.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 22 | 129 | $71,316 | $17,010 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 202 | $73,852 | $16,700 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 133 | $34,505 | $7,121 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $13,880 | $3,309 | 23.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $16,384 | $3,230 | 19.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $10,512 | $2,538 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $8,240 | $2,151 | 26.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $7,136 | $1,936 | 27.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 15 | 15 | $8,879 | $1,557 | 17.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 20 | 27 | $2,614 | $737.10 | 28.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 154 | 198 | $1,980 | $675.18 | 34.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 59 | 60 | $2,558 | $385.37 | 15.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 33 | 213 | $127,023 | $29,099 | 22.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 101 | 129 | $88,330 | $23,275 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 223 | $81,298 | $20,731 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 199 | 237 | $61,242 | $14,362 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $34,125 | $8,027 | 23.5% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2022 | 11 | 11 | $22,684 | $6,309 | 27.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 18 | 18 | $22,776 | $5,725 | 25.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 84 | 84 | $26,718 | $5,699 | 21.3% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2022 | 18 | 19 | $17,348 | $4,652 | 26.8% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 26 | 26 | $18,418 | $4,383 | 23.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 42 | 43 | $12,138 | $3,301 | 27.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 22 | $11,276 | $3,156 | 28.0% |
About Dr. John Bak, M.D
Dr. John Bak, M.D is a Urology healthcare provider based in Lakewood, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063413938.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Bak, M.D has received a total of $1,462 in payments from pharmaceutical and medical device companies, with $28.16 received in 2022. These payments were reported across 22 transactions from 7 companies. The most common payment nature is "Education" ($749.25).
As a Medicare-enrolled provider, Bak has provided services to 4,555 Medicare beneficiaries, totaling 6,094 services with total Medicare billing of $479,444. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Lakewood, WA
- Active Since 08/02/2005
- Last Updated 11/24/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1063413938
Products in Payments
- TITAN (Device) $1,191
- KEYTRUDA (Biological) $85.26
- (815) Thiola (Drug) $15.61
- Thiola (Drug) $7.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Lakewood
Dr. Jonathan Perley, M.d, M.D
Urology — Payments: $47,745
Dr. Brenton Winship, M.d, M.D
Urology — Payments: $5,801
Jacob Oppenheimer, M.d, M.D
Urology — Payments: $4,107
Dr. Jules Perley, M.d, M.D
Urology — Payments: $3,731
Dr. Neel Patel, M.d, M.D
Urology — Payments: $1,527
Dr. Mark Ferretti, M.d, M.D
Urology — Payments: $1,446